Dyslipidemia and oxidative stress in PCOS

Frontiers of Hormone Research

Volumn 40, Issue , 2013, Pages 51-63

  Macut, Djuro ^a   Bjekić Macut, Jelica ^a   Savić Radojević, Ana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; ATORVASTATIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FREE RADICAL; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; METFORMIN; NITRIC OXIDE SYNTHASE; OMEGA 3 FATTY ACID; ORAL CONTRACEPTIVE AGENT; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ROSIGLITAZONE; SIMVASTATIN; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOCTIC ACID; TRIACYLGLYCEROL; TROGLITAZONE; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN A; NITRIC OXIDE; INSULIN SENSITIZING AGENT; XANTHINE OXIDASE;

ABDOMINAL OBESITY; ADIPOSE TISSUE; AGING; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BODY COMPOSITION; CARDIOVASCULAR RISK; CELL COMPARTMENTALIZATION; CHOLESTEROL BLOOD LEVEL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFICACY; DRUG SAFETY; DYSLIPIDEMIA; ENZYME ACTIVITY; FATTY ACID OXIDATION; GLUCOSE TOLERANCE; HUMAN; HYPERANDROGENISM; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; LIPID METABOLISM; LIPID STORAGE; NONHUMAN; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PEROXIDATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREVALENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; ADOLESCENT; ADULT; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; DYSLIPIDEMIAS; FEMALE; INSULIN RESISTANCE; METABOLISM; PHYSIOLOGY; RISK FACTOR; DEFENSE MECHANISM; DIET SUPPLEMENTATION; OBESITY;

ADOLESCENT; ADULT; AGING; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DYSLIPIDEMIAS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERANDROGENISM; HYPERGLYCEMIA; INSULIN RESISTANCE; LIPOPROTEIN(A); NITRIC OXIDE; OXIDATIVE STRESS; POLYCYSTIC OVARY SYNDROME; REACTIVE OXYGEN SPECIES; RISK FACTORS; TRIGLYCERIDES;

EID: 84870269181     PISSN: 03013073     EISSN: 16623762     Source Type: Book Series    
DOI: 10.1159/000341683     Document Type: Article

References (30)

1. Legro RS, Kunselman AR, Dunaif A: Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 2001;111:607.
2. Gonzalez F, Rote NS, Minium J, Kirwan JP: Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:336.
3. Glintborg D, Mumm H, Hougaard D, Ravn P, Andersen M: Ethnic differences in rotterdam criteria and metabolic risk factors in a multiethnic group of women with PCOS studied in Denmark. Clin Endocrinol 2010;73:732.
4. Diamanti-Kandarakis E, Papavassiliou AG, Kandarakis SA, Chrousos GP: Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab 2007;18:280.
5. Hu Z, Wang Y, Qiao J, Li M, Chi H, Chen X: The role of family history in clinical symptoms and therapeutic outcomes of women with polycystic ovary syndrome. Int J Gynecol Obstet 2010;108:35.
6. Talbott E, Clerici A, Berga SL, Kuller L, Guzick D, Detre K, Daniels T, Engberg RA: Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a casecontrol study. J Clin Epidemiol 1998;51:415.
7. Macut D, Micić D, Cvijović G, Šumarac M, Kendereški A, Zorić S, Pejković D: Cardiovascular risk in adolescent and young adult obese females with polycystic ovary syndrome (PCOS). J Pediatr Endocrinol Metab 2001;14:1353.
8. Pirwany IR, Fleming R, Greer IA, Packard CJ, Sattar N: Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters. Clin Endocrinol (Oxf) 2001; 54:447.
9. Phelan N, O'Connor A, Kyaw-Tun T, Correia N, Boran G, Roche HM, Gibney J: Lipoprotein subclass patterns in women with polycystic ovary syndrome (PCOS) compared with equally insulin-resistant women without PCOS. J Clin Endocrinol Metab 2010;95:3933.
10. Macut D, Damjanović S, Panidis D, Spanos N, Glišić B, Petakov M, Rousso D, Kourtis A, Bjekić J, Milić N: Oxidised low-density lipoprotein concentration -early marker of an altered lipid metabolism in young women with PCOS. Eur J Endocrinol 2006; 155:131.
11. Berneis K, Rizzo M, Hersberger M, Rini GB, Di Fede G, Pepe I, Spinas GA, Carmina E: Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome. Int J Clin Pract 2009;63:56.
12. Koval KW, Setji TL, Reyes E, Brown AJ: Higher high-density lipoprotein cholesterol in African-American women with polycystic ovary syndrome compared with Caucasian counterparts. J Clin Endocrinol Metab 2010;95:E49.
13. Glueck CJ, Morrison JA, Goldenberg N, Wang P: Coronary heart disease risk factors in adult premenopausal white women. Metabolism 2009;58:714.
14. Wehr E, Gruber H-J, Giuliani A, Moller R, Pieber TR, Obermayer-Pietsch B: The lipid accumulation product is associated with impaired glucose tolerance in PCOS women. J Clin Endocrinol Metab 2011;96:E986.
15. Macut D, Panidis D, Glisić B, Spanos N, Petakov M, Bjekić J, Stanojlović O, Rousso D, Kourtis A, Bozić I, Damjanović S: Lipid and lipoprotein profile in women with polycystic ovary syndrome. Can J Physiol Pharmacol 2008;86:199.
16. Sies H: Oxidative stress: from basic research to clinical application. Am J Med 1991;91:31S.
17. Halliwell B: Reactive oxygen species in living systems. Source, biochemistry and role. Am J Med 1991;9:114.
18. Kuscu NK, Var A: Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome. Acta Obstet Gynecol 2009;88:612.
19. Macut D, Simic T, Lissounov A, Pljesa-Ercegovac M, Bozic I, Djukic T, Bjekic-Macut J, Matic M, Petakov M, Suvakov S, Damjanovic S, Savic-Radojevic A: Insulin resistance in non-obese women with polycystic ovary syndrome: relation to byproducts of oxidative stress. Exp Clin Endocrinol Diab 2011;119:451.
20. Fernandez-Sanchez A, Madrigal-Santillan E, Bautista M, Esquivel-Soto J, Morales-Gonzalez A, Esquivel-Chirino C, Durante-Montiel I, Sanchez-Rivera G, Valadez-Vega C, Morales-Gonzalez JA: Inflammation, oxidative stress, and obesity. Int J Mol Sci 2011;12:3117.
21. Simic DV, Mimic-Oka J, Pljesa-Ercegovac M, Savic-Radojevic A, Opacic M, Matic D, Ivanovic B, Simic T: Byproducts of oxidative protein damage and antioxidant enzyme activities in plasma of patients with different degrees of essential hypertension. Hypertension 2006;20:149.
22. Victor M, Rocha M, Banuls C, Sanchez-Serrano M, Sola E, Gomez M, Hernandez-Mijares A: Mitochondrial complex I impairment in leukocytes from polycystic ovary syndrome patients with insulin resistance. J Clin Endocrinol Metab 2009;94: 3505.
23. Lee YS, Kim AY, Choi JW, Kim M, Yasue S, Son HJ, Masuzaki H, Park KS, Kim JB: Dysregulation of adipose glutathione peroxidase 3 in obesity contributes to local and systemic oxidative stress. Mol Endocrinol 2008;22:2176.
24. Yilmaz M, Bukan N, Ayvaz G, Karakoc A, Toruner F, Cakir N, Arslan M: The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome. Hum Reprod 2005;20:3333.
25. Evans J, Maddux BA, Goldfine ID: The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 2005;7:1040.
26. Duleba AJ, Foyouzi N, Karaca M, Pehlivan T, Kwintkiewicz J, Behrman HR: Proliferation of ovarian theca-interstitial cells is modulated by antioxidants and oxidative stress. Hum Reprod 2004;19: 1519.
27. Kodaman PH, Duleba AJ: Statins: do they have potential in the treatment of polycystic ovary syndrome? Semin Reprod Med 2008;26:127.
28. Hoeger K, Davidson K, Kochman L, Cherry T, Kopin L, Guzick DS: The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials. J Clin Endocrinol Metab 2008;93:4299.
29. Raval AD, Hunter T, Stuckey B, Hart RJ: Statins for women with polycystic ovary syndrome not actively trying to conceive. Cochrane Database Syst Rev, DOI: 10.1002/14651858.
30. Cussons AJ, Watts GF, Mori TA, Stuckey BGA: Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy. J Clin Endocrinol Metab 2009;94:3842.